Research programme: MRSA vaccine therapeutics - Bavarian Nordic/ Evaxion Biotech/Technical University of DenmarkAlternative Names: Methicillin-resistant Staphylococcus aureus vaccines - Bavarian Nordic/Evaxion Biotech/Technical University of Denmark; MVA-BN based MRSA vaccines - Bavarian Nordic/Evaxion Biotech/Technical University of Denmark
Latest Information Update: 17 Feb 2016
At a glance
- Originator Bavarian Nordic; Technical university of denmark
- Developer Bavarian Nordic; Evaxion Biotech
- Class Vaccines
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Research Methicillin-resistant Staphylococcus aureus infections